TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1067327
log Bayes Factor = 1.60261
Chromosome 2   position 44,628,529  (GRCh37) Explore rs1067327 on Ensembl!
Variant rs1067327 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
T36-T50 Poisoning by drugs, medicaments and biological substances
0.974 0.026 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.972 0.028 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.971 0.029 0.000
T39.1 4-Aminophenol derivatives
0.962 0.038 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.961 0.039 0.000
T42.4 Benzodiazepines
0.936 0.064 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.927 0.073 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.924 0.076 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.857 0.143 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.852 0.148 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.848 0.152 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.829 0.171 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.826 0.174 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.825 0.175 0.000
T39.0 Salicylates
0.807 0.193 0.000
T36 Poisoning by systemic antibiotics
0.802 0.198 0.000
T43.2 Other and unspecified antidepressants
0.788 0.212 0.000
T40.4 Other synthetic narcotics
0.773 0.227 0.000
T42.1 Iminostilbenes
0.752 0.247 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.745 0.255 0.000
T43.6 Psychostimulants with abuse potential
0.728 0.272 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.724 0.276 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.723 0.277 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.712 0.288 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.709 0.291 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.703 0.297 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.699 0.301 0.000
T39.4 Antirheumatics, not elsewhere classified
0.697 0.303 0.000
T39.2 Pyrazolone derivatives
0.697 0.303 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.696 0.304 0.000
T42.3 Barbiturates
0.696 0.304 0.000
T42.2 Succinimides and oxazolidinediones
0.696 0.304 0.000
T36.0 Penicillins
0.694 0.306 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.689 0.311 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.680 0.320 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.675 0.325 0.000
T46.1 Calcium-channel blockers
0.660 0.340 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.657 0.343 0.000
T43.9 Psychotropic drug, unspecified
0.654 0.346 0.000
T42.0 Hydantoin derivatives
0.648 0.352 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.641 0.359 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.641 0.359 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.640 0.360 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.633 0.367 0.000
T40.6 Other and unspecified narcotics
0.616 0.384 0.000
T47.2 Stimulant laxatives
0.595 0.405 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.594 0.406 0.000
T40.8 Lysergide [LSD]
0.594 0.406 0.000
T40.7 Cannabis (derivatives)
0.594 0.406 0.000
T40.0 Opium
0.594 0.406 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.591 0.409 0.000
T46.7 Peripheral vasodilators
0.591 0.409 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.590 0.410 0.000
T36.4 Tetracyclines
0.586 0.414 0.000
T47.4 Other laxatives
0.576 0.424 0.000
T36.9 Systemic antibiotic, unspecified
0.575 0.425 0.000
T36.8 Other systemic antibiotics
0.575 0.425 0.000
T36.7 Antifungal antibiotics, systemically used
0.575 0.425 0.000
T36.6 Rifamycins
0.575 0.425 0.000
T36.5 Aminoglycosides
0.575 0.425 0.000
T36.2 Chloramphenicol group
0.575 0.425 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.575 0.425 0.000
T40.2 Other opioids
0.561 0.439 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.559 0.440 0.000
T40.1 Heroin
0.555 0.444 0.000
T47.6 Antidiarrhoeal drugs
0.550 0.450 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.550 0.450 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.549 0.451 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.549 0.451 0.000
T40.3 Methadone
0.548 0.452 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.538 0.462 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.537 0.463 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.534 0.466 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.534 0.466 0.000
T47.7 Emetics
0.534 0.466 0.000
T47.5 Digestants
0.534 0.466 0.000
T47.3 Saline and osmotic laxatives
0.534 0.466 0.000
T36.3 Macrolides
0.528 0.471 0.000
T48.5 Anti-common-cold drugs
0.528 0.472 0.000
T40.5 Cocaine
0.524 0.476 0.000
T38.5 Other oestrogens and progestogens
0.524 0.476 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.522 0.478 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.519 0.481 0.000
T48.4 Expectorants
0.519 0.481 0.000
T48.3 Antitussives
0.519 0.481 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.519 0.481 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.519 0.481 0.000
T48.0 Oxytocic drugs
0.519 0.481 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.517 0.482 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.515 0.485 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.514 0.486 0.000
T38.9 Other and unspecified hormone antagonists
0.510 0.490 0.000
T38.7 Androgens and anabolic congeners
0.510 0.490 0.000
T38.4 Oral contraceptives
0.510 0.490 0.000
T38.2 Antithyroid drugs
0.510 0.490 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.507 0.493 0.000
T41.5 Therapeutic gases
0.501 0.499 0.000
T41.4 Anaesthetic, unspecified
0.501 0.499 0.000
T41.3 Local anaesthetics
0.501 0.499 0.000
T41.2 Other and unspecified general anaesthetics
0.501 0.499 0.000
T41.1 Intravenous anaesthetics
0.501 0.499 0.000
T41.0 Inhaled anaesthetics
0.501 0.499 0.000
T38.0 Glucocorticoids and synthetic analogues
0.493 0.507 0.000
T50.1 Loop [high-ceiling] diuretics
0.493 0.507 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.493 0.507 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.488 0.512 0.000
T37.5 Antiviral drugs
0.488 0.512 0.000
T37.4 Anthelminthics
0.488 0.512 0.000
T37.3 Other antiprotozoal drugs
0.488 0.512 0.000
T37.1 Antimycobacterial drugs
0.488 0.512 0.000
T37.0 Sulphonamides
0.488 0.512 0.000
T50.4 Drugs affecting uric acid metabolism
0.483 0.517 0.000
T50.7 Analeptics and opioid receptor antagonists
0.471 0.529 0.000
T50.5 Appetite depressants
0.471 0.529 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.471 0.529 0.000
T50.0 Mineralocorticoids and their antagonists
0.471 0.529 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.470 0.530 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.463 0.536 0.000
T49.9 Topical agent, unspecified
0.459 0.540 0.000
T49.8 Other topical agents
0.459 0.540 0.000
T49.7 Dental drugs, topically applied
0.459 0.540 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.459 0.540 0.000
T49.5 Ophthalmological drugs and preparations
0.459 0.540 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.459 0.540 0.000
T49.3 Emollients, demulcents and protectants
0.459 0.540 0.000
T49.2 Local astringents and local detergents
0.459 0.540 0.000
T49.1 Antipruritics
0.459 0.540 0.000
T47.0 Histamine H(2)-receptor antagonists
0.457 0.543 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.441 0.559 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.440 0.559 0.000
T50.8 Diagnostic agents
0.423 0.576 0.000
T45.2 Vitamins, not elsewhere classified
0.420 0.580 0.000
T38.1 Thyroid hormones and substitutes
0.405 0.595 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.401 0.598 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.394 0.605 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.394 0.605 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.394 0.605 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.394 0.605 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.394 0.605 0.000
T44.0 Anticholinesterase agents
0.394 0.605 0.000
T45.4 Iron and its compounds
0.383 0.617 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.382 0.618 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.374 0.626 0.000
T45.8 Other primarily systemic and haematological agents
0.374 0.626 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.374 0.626 0.000
T45.6 Fibrinolysis-affecting drugs
0.374 0.626 0.000
T45.3 Enzymes, not elsewhere classified
0.374 0.626 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.368 0.631 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.358 0.642 0.000
T45.0 Antiallergic and antiemetic drugs
0.349 0.651 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.280 0.720 0.000
T45.5 Anticoagulants
0.261 0.738 0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.225 0.775 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.960 0.040
E27.1 Primary adrenocortical insufficiency
0.000 0.962 0.038
E27 Other disorders of adrenal gland
0.000 0.962 0.037
N20.0 Calculus of kidney
0.035 0.965 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.032 0.968 0.000
E24 Cushing's syndrome
0.000 0.968 0.032
E20-E35 Disorders of other endocrine glands
0.000 0.968 0.032
N20 Calculus of kidney and ureter
0.031 0.969 0.000
N20.1 Calculus of ureter
0.031 0.969 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.971 0.029
E28 Ovarian dysfunction
0.000 0.972 0.028
E27.8 Other specified disorders of adrenal gland
0.000 0.972 0.028
E27.5 Adrenomedullary hyperfunction
0.000 0.973 0.027
E27.0 Other adrenocortical overactivity
0.000 0.973 0.027
E24.0 Pituitary-dependent Cushing's disease
0.000 0.973 0.027
C79 Secondary malignant neoplasm of other sites
0.027 0.973 0.000
N20.9 Urinary calculus, unspecified
0.027 0.973 0.000
E24.2 Drug-induced Cushing's syndrome
0.000 0.973 0.027
E28.3 Primary ovarian failure
0.000 0.973 0.027
C79.7 Secondary malignant neoplasm of adrenal gland
0.026 0.974 0.000
E29 Testicular dysfunction
0.000 0.974 0.026
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.975 0.025
E24.8 Other Cushing's syndrome
0.000 0.975 0.025
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.025 0.975 0.000
E25 Adrenogenital disorders
0.000 0.976 0.023
E34 Other endocrine disorders
0.000 0.977 0.023
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.977 0.023
E24.3 Ectopic ACTH syndrome
0.000 0.977 0.023
E24.1 Nelson's syndrome
0.000 0.977 0.023
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.977 0.023
E30 Disorders of puberty, not elsewhere classified
0.000 0.977 0.023
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.023 0.977 0.000
E31 Polyglandular dysfunction
0.000 0.978 0.022
C79.2 Secondary malignant neoplasm of skin
0.022 0.978 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.978 0.022
N20.2 Calculus of kidney with calculus of ureter
0.021 0.979 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.021 0.979 0.000
E32 Diseases of thymus
0.000 0.979 0.021
E20 Hypoparathyroidism
0.000 0.979 0.021
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.979 0.021
E22 Hyperfunction of pituitary gland
0.000 0.979 0.021
E28.9 Ovarian dysfunction, unspecified
0.000 0.980 0.020
E28.8 Other ovarian dysfunction
0.000 0.980 0.020
E28.1 Androgen excess
0.000 0.980 0.020
E28.0 Oestrogen excess
0.000 0.980 0.020
E23 Hypofunction and other disorders of pituitary gland
0.000 0.980 0.020
E34.8 Other specified endocrine disorders
0.000 0.980 0.020
K11.5 Sialolithiasis
0.000 0.980 0.020
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.980 0.020
C79.9 Secondary malignant neoplasm, unspecified site
0.020 0.980 0.000
E27.9 Disorder of adrenal gland, unspecified
0.000 0.981 0.019
E26 Hyperaldosteronism
0.000 0.981 0.019
E27.2 Addisonian crisis
0.000 0.981 0.019
E29.8 Other testicular dysfunction
0.000 0.981 0.018
E29.0 Testicular hyperfunction
0.000 0.981 0.018
E28.2 Polycystic ovarian syndrome
0.000 0.981 0.019
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.018 0.982 0.000
E23.0 Hypopituitarism
0.000 0.982 0.018
E29.1 Testicular hypofunction
0.000 0.982 0.018
E22.1 Hyperprolactinaemia
0.000 0.982 0.018
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.982 0.018
A63.0 Anogenital (venereal) warts
0.000 0.982 0.018
E25.9 Adrenogenital disorder, unspecified
0.000 0.983 0.017
E25.8 Other adrenogenital disorders
0.000 0.983 0.017
E34.5 Androgen resistance syndrome
0.000 0.983 0.017
E34.4 Constitutional tall stature
0.000 0.983 0.017
E34.3 Short stature, not elsewhere classified
0.000 0.983 0.017
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.983 0.017
E34.1 Other hypersecretion of intestinal hormones
0.000 0.983 0.017
E30.9 Disorder of puberty, unspecified
0.000 0.983 0.016
E30.8 Other disorders of puberty
0.000 0.983 0.016
E30.1 Precocious puberty
0.000 0.983 0.016
E30.0 Delayed puberty
0.000 0.983 0.016
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.983 0.016
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.983 0.016
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.983 0.016
O34.2 Maternal care due to uterine scar from previous surgery
0.016 0.984 0.000
E31.9 Polyglandular dysfunction, unspecified
0.000 0.984 0.016
E31.8 Other polyglandular dysfunction
0.000 0.984 0.016
E31.1 Polyglandular hyperfunction
0.000 0.984 0.016
E21.4 Other specified disorders of parathyroid gland
0.000 0.984 0.016
E31.0 Autoimmune polyglandular failure
0.000 0.984 0.016
C79.6 Secondary malignant neoplasm of ovary
0.016 0.984 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.984 0.016
E34.9 Endocrine disorder, unspecified
0.000 0.985 0.015
E32.9 Disease of thymus, unspecified
0.000 0.985 0.015
E32.1 Abscess of thymus
0.000 0.985 0.015
E32.0 Persistent hyperplasia of thymus
0.000 0.985 0.015
E22.0 Acromegaly and pituitary gigantism
0.000 0.985 0.015
E20.1 Pseudohypoparathyroidism
0.000 0.985 0.015
E20.0 Idiopathic hypoparathyroidism
0.000 0.985 0.015
E20.8 Other hypoparathyroidism
0.000 0.985 0.015
E22.8 Other hyperfunction of pituitary gland
0.000 0.985 0.015
E21.2 Other hyperparathyroidism
0.000 0.985 0.015
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.985 0.015
E23.1 Drug-induced hypopituitarism
0.000 0.985 0.015
E34.0 Carcinoid syndrome
0.000 0.985 0.014
O34 Maternal care for known or suspected abnormality of pelvic organs
0.014 0.986 0.000
E26.8 Other hyperaldosteronism
0.000 0.986 0.014
E26.1 Secondary hyperaldosteronism
0.000 0.986 0.014
S02.10 Fracture of base of skull (closed)
0.014 0.986 0.000
E23.7 Disorder of pituitary gland, unspecified
0.000 0.986 0.013
E32.8 Other diseases of thymus
0.000 0.987 0.013
O34.8 Maternal care for other abnormalities of pelvic organs
0.013 0.987 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.987 0.013
E23.2 Diabetes insipidus
0.000 0.987 0.013
O34.4 Maternal care for other abnormalities of cervix
0.013 0.987 0.000
E20.9 Hypoparathyroidism, unspecified
0.000 0.987 0.013
E26.9 Hyperaldosteronism, unspecified
0.000 0.987 0.013
E26.0 Primary hyperaldosteronism
0.000 0.988 0.012
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level
0.000 0.988 0.012
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
0.012 0.988 0.000
N18.5 Chronic kidney disease, stage 5
0.000 0.989 0.011
O34.6 Maternal care for abnormality of vagina
0.011 0.989 0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level
0.000 0.989 0.011
O34.7 Maternal care for abnormality of vulva and perineum
0.011 0.989 0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified
0.010 0.990 0.000
O34.5 Maternal care for other abnormalities of gravid uterus
0.010 0.990 0.000
S66 Injury of muscle and tendon at wrist and hand level
0.000 0.990 0.010
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.990 0.010
K11 Diseases of salivary glands
0.000 0.990 0.010
O34.1 Maternal care for tumour of corpus uteri
0.010 0.990 0.000
O34.0 Maternal care for congenital malformation of uterus
0.010 0.990 0.000
C83.3 Large cell (diffuse)
0.000 0.990 0.010
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
0.009 0.991 0.000
C83.0 Small cell (diffuse)
0.000 0.991 0.009
E23.6 Other disorders of pituitary gland
0.001 0.991 0.009
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level
0.000 0.991 0.009
C83.7 Burkitt's tumour
0.000 0.991 0.009
K11.6 Mucocele of salivary gland
0.000 0.991 0.009
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.991 0.009
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
0.009 0.991 0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
0.009 0.991 0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
0.000 0.991 0.009
S42.20 Fracture of upper end of humerus (closed)
0.009 0.991 0.000
K11.3 Abscess of salivary gland
0.000 0.991 0.009
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level
0.000 0.991 0.009
C83.1 Small cleaved cell (diffuse)
0.000 0.991 0.008
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.992 0.008
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.992 0.008
Z57 Occupational exposure to risk-factors
0.008 0.992 0.000
Z57.3 Occupational exposure to other air contaminants
0.008 0.992 0.000
S66.8 Injury of other muscles and tendons at wrist and hand level
0.000 0.992 0.008
S66.9 Injury of unspecified muscle and tendon at wrist and hand level
0.000 0.992 0.008
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.992 0.008
K11.2 Sialoadenitis
0.000 0.992 0.008
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level
0.000 0.992 0.007
Z29.2 Other prophylactic chemotherapy
0.008 0.992 0.000
C83.6 Undifferentiated (diffuse)
0.000 0.992 0.007
C83.4 Immunoblastic (diffuse)
0.000 0.992 0.007
O34.3 Maternal care for cervical incompetence
0.007 0.992 0.000
Z57.5 Occupational exposure to toxic agents in other industries
0.007 0.993 0.000
K11.4 Fistula of salivary gland
0.000 0.993 0.007
K11.0 Atrophy of salivary gland
0.000 0.993 0.007
C83.5 Lymphoblastic (diffuse)
0.000 0.993 0.007
Z57.2 Occupational exposure to dust
0.007 0.993 0.000
K11.9 Disease of salivary gland, unspecified
0.000 0.993 0.007
C83.2 Mixed small and large cell (diffuse)
0.000 0.993 0.007
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
0.007 0.993 0.000
K11.8 Other diseases of salivary glands
0.000 0.993 0.007
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances
0.007 0.993 0.000
K66.8 Other specified disorders of peritoneum
0.000 0.993 0.007
K56.1 Intussusception
0.007 0.993 0.000
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level
0.000 0.993 0.007
Z63 Other problems related to primary support group, including family circumstances
0.007 0.993 0.000
K56.5 Intestinal adhesions [bands] with obstruction
0.007 0.993 0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
0.007 0.993 0.000
Z63.7 Other stressful life events affecting family and household
0.007 0.993 0.000
Z29.1 Prophylactic immunotherapy
0.007 0.993 0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
0.007 0.993 0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium
0.007 0.993 0.000
Z56 Problems related to employment and unemployment
0.007 0.993 0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
0.006 0.994 0.000
C81.9 Hodgkin's disease, unspecified
0.000 0.994 0.006
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level
0.000 0.994 0.006
Z58 Problems related to physical environment
0.006 0.994 0.000
E21.3 Hyperparathyroidism, unspecified
0.000 0.994 0.006
C84.5 Other and unspecified T-cell lymphomas
0.000 0.994 0.006
C81 Hodgkin's disease
0.000 0.994 0.006
K56 Paralytic ileus and intestinal obstruction without hernia
0.006 0.994 0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
0.006 0.994 0.000
Z64 Problems related to certain psychosocial circumstances
0.006 0.994 0.000
K11.1 Hypertrophy of salivary gland
0.000 0.994 0.006
A63.8 Other specified predominantly sexually transmitted diseases
0.000 0.994 0.006
K11.7 Disturbances of salivary secretion
0.000 0.994 0.006
Z57.9 Occupational exposure to unspecified risk-factor
0.006 0.994 0.000
Z57.7 Occupational exposure to vibration
0.006 0.994 0.000
Z57.6 Occupational exposure to extreme temperature
0.006 0.994 0.000
Z57.4 Occupational exposure to toxic agents in agriculture
0.006 0.994 0.000
Z57.1 Occupational exposure to radiation
0.006 0.994 0.000
Z57.0 Occupational exposure to noise
0.006 0.994 0.000
Z29 Need for other prophylactic measures
0.006 0.994 0.000
Z56.6 Other physical and mental strain related to work
0.006 0.994 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.994 0.006
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.994 0.006
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level
0.000 0.994 0.006
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.994 0.006
Z58.5 Exposure to other pollution
0.006 0.994 0.000
C81.7 Other Hodgkin's disease
0.000 0.994 0.006
E21.0 Primary hyperparathyroidism
0.000 0.994 0.006
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.006 0.994 0.000
K56.7 Ileus, unspecified
0.006 0.994 0.000
S02.1 Fracture of base of skull
0.006 0.994 0.000
Z63.4 Disappearance and death of family member
0.006 0.994 0.000
Z65 Problems related to other psychosocial circumstances
0.005 0.994 0.000
Z63.5 Disruption of family by separation and divorce
0.005 0.994 0.000
M11.26 Other chondrocalcinosis (Lower leg)
0.005 0.995 0.000
Z62 Other problems related to upbringing
0.005 0.995 0.000
Z55 Problems related to education and literacy
0.005 0.995 0.000
Z64.0 Problems related to unwanted pregnancy
0.005 0.995 0.000
Z56.0 Unemployment, unspecified
0.005 0.995 0.000
Z63.6 Dependent relative needing care at home
0.005 0.995 0.000
Z63.9 Problem related to primary support group, unspecified
0.005 0.995 0.000
Z63.3 Absence of family member
0.005 0.995 0.000
Z63.2 Inadequate family support
0.005 0.995 0.000
Z63.1 Problems in relationship with parents and in-laws
0.005 0.995 0.000
Z56.3 Stressful work schedule
0.005 0.995 0.000
K56.3 Gallstone ileus
0.005 0.995 0.000
K56.0 Paralytic ileus
0.005 0.995 0.000
Z61 Problems related to negative life events in childhood
0.005 0.995 0.000
Z56.4 Discord with boss and workmates
0.005 0.995 0.000
O94-O99 Other obstetric conditions, not elsewhere classified
0.005 0.995 0.000
Z56.7 Other and unspecified problems related to employment
0.005 0.995 0.000
Z63.0 Problems in relationship with spouse or partner
0.005 0.995 0.000
C95 Leukaemia of unspecified cell type
0.000 0.995 0.005
Z56.5 Uncongenial work
0.005 0.995 0.000
Z56.2 Threat of job loss
0.005 0.995 0.000
Z56.1 Change of job
0.005 0.995 0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
0.005 0.995 0.000
Z58.1 Exposure to air pollution
0.005 0.995 0.000
Z58.7 Exposure to tobacco smoke
0.005 0.995 0.000
Z58.9 Problem related to physical environment, unspecified
0.005 0.995 0.000
Z58.8 Other problems related to physical environment
0.005 0.995 0.000
Z58.6 Inadequate drinking-water supply
0.005 0.995 0.000
Z58.4 Exposure to radiation
0.005 0.995 0.000
Z58.3 Exposure to soil pollution
0.005 0.995 0.000
Z58.2 Exposure to water pollution
0.005 0.995 0.000
Z58.0 Exposure to noise
0.005 0.995 0.000
C81.2 Mixed cellularity
0.000 0.995 0.005
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.995 0.005
C81.3 Lymphocytic depletion
0.000 0.995 0.005
Z29.8 Other specified prophylactic measures
0.005 0.995 0.000
Z57.8 Occupational exposure to other risk-factors
0.004 0.995 0.000
C81.0 Lymphocytic predominance
0.000 0.995 0.005
Z63.8 Other specified problems related to primary support group
0.005 0.995 0.000
Z64.4 Discord with counsellors
0.004 0.995 0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful
0.004 0.995 0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
0.004 0.995 0.000
Z64.1 Problems related to multiparity
0.004 0.995 0.000
Z65.9 Problem related to unspecified psychosocial circumstances
0.004 0.995 0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.005 0.995 0.000
Z29.9 Prophylactic measure, unspecified
0.004 0.995 0.000
Z65.3 Problems related to other legal circumstances
0.004 0.995 0.000
C84.4 Peripheral T-cell lymphoma
0.000 0.995 0.004
C95.9 Leukaemia, unspecified
0.000 0.995 0.004
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.996 0.004
Z59 Problems related to housing and economic circumstances
0.004 0.996 0.000
C85.0 Lymphosarcoma
0.000 0.996 0.004
C86 Other specified types of T/NK-cell lymphoma
0.000 0.996 0.004
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.996 0.004
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.996 0.004
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.996 0.004
C84.3 Lymphoepithelioid lymphoma
0.000 0.996 0.004
C84.2 T-zone lymphoma
0.000 0.996 0.004
C84.1 Sezary's diease
0.000 0.996 0.004
K56.6 Other and unspecified intestinal obstruction
0.004 0.996 0.000
Z60 Problems related to social environment
0.004 0.996 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.996 0.004
K56.4 Other impaction of intestine
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.000 0.996 0.004
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.996 0.004
Z65.5 Exposure to disaster, war and other hostilities
0.004 0.996 0.000
Z65.4 Victim of crime and terrorism
0.004 0.996 0.000
Z65.2 Problems related to release from prison
0.004 0.996 0.000
Z65.1 Imprisonment and other incarceration
0.004 0.996 0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment
0.004 0.996 0.000
S42.2 Fracture of upper end of humerus
0.004 0.996 0.000
Z55.9 Problems relating to education and literacy, unspecified
0.004 0.996 0.000
Z55.8 Other problems relating to education and literacy
0.004 0.996 0.000
Z55.4 Educational maladjustment and discord with teachers and classmates
0.004 0.996 0.000
Z55.3 Underachievement in school
0.004 0.996 0.000
Z55.2 Failed examinations
0.004 0.996 0.000
Z55.1 Schooling unavailable and unattainable
0.004 0.996 0.000
Z55.0 Illiteracy and low-level literacy
0.004 0.996 0.000
Z62.9 Problem related to upbringing, unspecified
0.004 0.996 0.000
Z62.8 Other specified problems related to upbringing
0.004 0.996 0.000
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing
0.004 0.996 0.000
Z62.5 Other problems related to neglect in upbringing
0.004 0.996 0.000
Z62.4 Emotional neglect of child
0.004 0.996 0.000
Z62.3 Hostility towards and scapegoating of child
0.004 0.996 0.000
Z62.2 Institutional upbringing
0.004 0.996 0.000
Z62.1 Parental overprotection
0.004 0.996 0.000
Z62.0 Inadequate parental supervision and control
0.004 0.996 0.000
C91 Lymphoid leukaemia
0.000 0.996 0.004
O03.4 Incomplete, without complication
0.004 0.996 0.000
C95.0 Acute leukaemia of unspecified cell type
0.000 0.996 0.004
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.004 0.996 0.000
Z61.9 Negative life events in childhood, unspecified
0.004 0.996 0.000
Z61.7 Personal frightening experience in childhood
0.004 0.996 0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group
0.004 0.996 0.000
Z61.3 Events resulting in loss of self-esteem in childhood
0.004 0.996 0.000
Z61.2 Altered pattern of family relationships in childhood
0.004 0.996 0.000
Z61.1 Removal from home in childhood
0.004 0.996 0.000
Z61.0 Loss of love relationship in childhood
0.004 0.996 0.000
C94 Other leukaemias of specified cell type
0.000 0.996 0.004
O97 Death from sequelae of direct obstetric causes
0.004 0.996 0.000
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery
0.004 0.996 0.000
O95 Obstetric death of unspecified cause
0.004 0.996 0.000
O94 Sequelae of complication of pregnancy, childbirth and the puerperium
0.004 0.996 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.996 0.004
C95.7 Other leukaemia of unspecified cell type
0.000 0.996 0.004
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.996 0.004
Z61.8 Other negative life events in childhood
0.004 0.996 0.000
Z61.6 Problems related to alleged physical abuse of child
0.004 0.996 0.000
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
0.004 0.996 0.000
C93 Monocytic leukaemia
0.000 0.996 0.004
S02.11 Fracture of base of skull (open)
0.004 0.996 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.996 0.004
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group
0.004 0.996 0.000
C91.0 Acute lymphoblastic leukaemia
0.000 0.996 0.004
Z60.8 Other problems related to social environment
0.004 0.996 0.000
C91.9 Lymphoid leukaemia, unspecified
0.000 0.996 0.004
M11.2 Other chondrocalcinosis
0.004 0.996 0.000
O03 Spontaneous abortion
0.004 0.996 0.000
C84.0 Mycosis fungoides
0.000 0.996 0.003
Z65.8 Other specified problems related to psychosocial circumstances
0.003 0.996 0.000
D27 Benign neoplasm of ovary
0.004 0.996 0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria
0.004 0.996 0.000
Z60.9 Problem related to social environment, unspecified
0.003 0.996 0.000
Z94.8 Other transplanted organ and tissue status
0.000 0.996 0.004
Z59.9 Problem relating to housing and economic circumstances, unspecified
0.003 0.996 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.997 0.003
C96.8 Histiocytic sarcoma
0.000 0.997 0.003
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.997 0.003
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.997 0.003
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.997 0.003
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.997 0.003
C96.3 True histiocytic lymphoma
0.000 0.997 0.003
C96.2 Malignant mast cell tumour
0.000 0.997 0.003
C96.1 Malignant histiocytosis
0.000 0.997 0.003
C96.0 Letterer-Siwe disease
0.000 0.997 0.003
Z59.7 Insufficient social insurance and welfare support
0.003 0.997 0.000
Z59.6 Low income
0.003 0.997 0.000
Z59.5 Extreme poverty
0.003 0.997 0.000
Z59.3 Problems related to living in residential institution
0.003 0.997 0.000
Z59.0 Homelessness
0.003 0.997 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.997 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.